1. Home
  2. STRA vs GLPG Comparison

STRA vs GLPG Comparison

Compare STRA & GLPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRA
  • GLPG
  • Stock Information
  • Founded
  • STRA 2017
  • GLPG 1999
  • Country
  • STRA United States
  • GLPG Belgium
  • Employees
  • STRA N/A
  • GLPG N/A
  • Industry
  • STRA Other Consumer Services
  • GLPG Biotechnology: Pharmaceutical Preparations
  • Sector
  • STRA Real Estate
  • GLPG Health Care
  • Exchange
  • STRA Nasdaq
  • GLPG Nasdaq
  • Market Cap
  • STRA 2.0B
  • GLPG 1.8B
  • IPO Year
  • STRA 1996
  • GLPG 2005
  • Fundamental
  • Price
  • STRA $89.26
  • GLPG $25.32
  • Analyst Decision
  • STRA
  • GLPG Sell
  • Analyst Count
  • STRA 0
  • GLPG 4
  • Target Price
  • STRA N/A
  • GLPG $25.33
  • AVG Volume (30 Days)
  • STRA 227.0K
  • GLPG 466.6K
  • Earning Date
  • STRA 04-24-2025
  • GLPG 04-23-2025
  • Dividend Yield
  • STRA 2.72%
  • GLPG N/A
  • EPS Growth
  • STRA 11.28
  • GLPG N/A
  • EPS
  • STRA 4.68
  • GLPG N/A
  • Revenue
  • STRA $1,233,270,000.00
  • GLPG $311,493,731.00
  • Revenue This Year
  • STRA $6.07
  • GLPG N/A
  • Revenue Next Year
  • STRA $5.18
  • GLPG N/A
  • P/E Ratio
  • STRA $18.85
  • GLPG N/A
  • Revenue Growth
  • STRA 5.72
  • GLPG 18.32
  • 52 Week Low
  • STRA $74.28
  • GLPG $22.36
  • 52 Week High
  • STRA $123.41
  • GLPG $31.23
  • Technical
  • Relative Strength Index (RSI)
  • STRA 68.16
  • GLPG 45.40
  • Support Level
  • STRA $87.76
  • GLPG $25.20
  • Resistance Level
  • STRA $89.94
  • GLPG $27.64
  • Average True Range (ATR)
  • STRA 2.58
  • GLPG 0.59
  • MACD
  • STRA 1.19
  • GLPG -0.09
  • Stochastic Oscillator
  • STRA 94.68
  • GLPG 23.93

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

Share on Social Networks: